Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high...
7 insider purchases on record · latest filing 2023-10-03.
Insiders have also filed 67 sale transactions at DNTH.